Larry Douglas Altstiel

Insider Reports History

Entity
Individual
Location
C/O Neurotrope, Inc., 50 Park Place, Suite 1401, Newark, NJ
Signature
/s/ Max A. Milbury, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Larry Douglas Altstiel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ProMIS Neurosciences Inc. Chief Medical Officer Option (right to buy) 175K Nov 18, 2024 Direct

Insider Reports Filed by Larry Douglas Altstiel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PMN ProMIS Neurosciences Inc. Nov 18, 2024 1 $0 4 Nov 20, 2024 Chief Medical Officer
PMN ProMIS Neurosciences Inc. Oct 26, 2023 1 $0 4 Oct 30, 2023 Chief Medical Officer
PMN ProMIS Neurosciences Inc. Jul 7, 2022 0 $0 3 Jul 7, 2022 Chief Medical Officer